Jaedyn Bonner, | |
1032 Crosswinds Ct, Wentzville, MO 63385-4836 | |
(844) 853-8937 | |
Not Available |
Full Name | Jaedyn Bonner |
---|---|
Gender | Female |
Speciality | Psychologist |
Location | 1032 Crosswinds Ct, Wentzville, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548932973 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | 2021039868 (Missouri) | Primary |
Entity Name | Compass Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285619494 PECOS PAC ID: 1951206754 Enrollment ID: O20040408000955 |
News Archive
Researchers who analyzed data for São Paulo state, Brazil, found the highest rates of newborn mortality from asphyxia in cities in the south, southeast and north of the state between 2004 and 2013.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT-, can detect lung cancer in sputum samples with high sensitivity and specificity. The data was presented at the International Association for the Study of Lung Cancer 15th World Conference on Lung Cancer.
Many normal children display low levels of the traits associated with ADHD – behaving in an impulsive, inattentive, and restless fashion – which will not cause problems.
Glenmark Pharmaceuticals today announced that its Novel Chemical Entity "Revamilast" (GRC 4039) has initiated Phase IIb human dose range finding trials globally. Revamilast is an orally active, potent and selective inhibitor of phosphodiesterase 4 (PDE 4) that is currently being developed by Glenmark for the treatment of chronic inflammatory disorders such as Asthma, Rheumatoid Arthritis (RA) and other inflammatory diseases.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Jaedyn Bonner, 1800 Community, Clinton, MO 64735-8804 Ph: (844) 853-8937 | Jaedyn Bonner, 1032 Crosswinds Ct, Wentzville, MO 63385-4836 Ph: (844) 853-8937 |
News Archive
Researchers who analyzed data for São Paulo state, Brazil, found the highest rates of newborn mortality from asphyxia in cities in the south, southeast and north of the state between 2004 and 2013.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies, announced today that it will present preclinical data in two poster presentations at the 102nd American Association for Cancer Research annual meeting in Orlando, FL during April 2-6, 2011.
VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT-, can detect lung cancer in sputum samples with high sensitivity and specificity. The data was presented at the International Association for the Study of Lung Cancer 15th World Conference on Lung Cancer.
Many normal children display low levels of the traits associated with ADHD – behaving in an impulsive, inattentive, and restless fashion – which will not cause problems.
Glenmark Pharmaceuticals today announced that its Novel Chemical Entity "Revamilast" (GRC 4039) has initiated Phase IIb human dose range finding trials globally. Revamilast is an orally active, potent and selective inhibitor of phosphodiesterase 4 (PDE 4) that is currently being developed by Glenmark for the treatment of chronic inflammatory disorders such as Asthma, Rheumatoid Arthritis (RA) and other inflammatory diseases.
› Verified 5 days ago
Fatemeh Akbari, PLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937 | |
Andrew Peter Wislocki, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 888-403-1071 | |
Dr. Ursula Wiese Marsh, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 219 Creekside Office Drive, Wentzville, MO 63385 Phone: 636-357-0136 Fax: 636-639-1004 | |
Chandler Puhy, LP Psychologist Medicare: Medicare Enrolled Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937 | |
Cynthia L Mueller, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: -- | |
Kayla Elayne Campbell, PHD, PLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937 | |
Rosemarie Kugler, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 888-403-1071 |